Reuters logo
BRIEF-Pfizer says new data in Crohn's disease patients shows similar efficacy and safety profiles for Inflectra and Remicade A
February 17, 2017 / 6:26 PM / 10 months ago

BRIEF-Pfizer says new data in Crohn's disease patients shows similar efficacy and safety profiles for Inflectra and Remicade A

Feb 17 (Reuters) - Pfizer Inc

* New data in crohn’s disease patients shows similar efficacy and safety profiles for inflectra® and remicade®a

* Pfizer inc - further results on longer-term safety and efficacy of inflectra from ongoing 54-week study in cd are expected later this year Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below